Johnson & Johnson’s “Non-Enforcement” of Bedaquiline Patents: What has Actually been Gained?
SpicyIP
NOVEMBER 9, 2023
Regardless of who invested how much, Janssen does have ownership over at least 5 patents, as mentioned above, and this is what we look at below. This patent (corresponding Indian application number: 220/DELNP/2005 ) has already expired in the ‘market’ with the most number of patients, i.e. India. Fn 12 of the same paper).
Let's personalize your content